Views & Analysis Digital healthcare round-up: ASCO apps, public health, weara... A round-up of this week's top digital healthcare news. Marco Ricci reports.
Articles Mobile shift in pharma communications Balance engagement and compliance with a non-promotional, patient-centric approach and ongoing development for app success.
Articles Oncology apps and opportunities for pharma Kevin Bambury examines what apps are being developed, their usefulness, and where there are gaps to fill.
Articles The ‘Wild West’ of health apps Health apps could eventually play a major role in managing health – but more evidence is needed to back up claims and dispel hype, says Richard Meyer.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.